Rotate device

Please turn your device

Bormioli Pharma accelerates sustainability: 50% of products will have a low environmental impact by 2025

Bormioli Pharma 15 July 2021

Bormioli Pharma, committed to the search for sustainable solutions for more than 15 years, announces a new goal: to use 50% of sustainable raw materials for the manufacture of its products by 2025, tripling their current usage.

Despite the highly regulated nature of the pharmaceutical industry which makes making change more complex, the sector seems to be ready to embrace the challenge of the ecological transition: according to a survey conducted by Bormioli Pharma on its customer base, more than 90% of companies in the pharmaceutical sector consider the quest for new sustainable packaging solutions a priority. This focus has already translated into an increase in the sales of bottles, closures and accessories made from recycled or bio-based materials, which reached +50% in 2020 and +130% in the last three years. These are significant results that the company has been able to achieve thanks to its ability to combine sustainable materials with the high quality and safety standards required by the industry.

“Sustainability is quickly becoming an agenda point of pharmaceutical industries around the world and, as primary packaging manufacturers, we feel the responsibility to support the industry in this transition, while sustaining the health of people and the planet” commented Andrea Lodetti, CEO of Bormioli Pharma. “We have always invested in the research and development of concrete, sustainable solutions, but today we want to make this commitment a differentiating element of our growth strategy by aligning it to medium-term objectives.”

Other solutions are currently being developed and tested, such as the creation of an innovative plastic made from carbon emissions recovery, the introduction of eco-design guidelines that encourage a lower use of virgin materials, the simplification of components and enhanced recycling.

Bormioli Pharma’s commitment is part of the company’s broader approach to corporate responsibility, which spans from manufacturing to the supply chain. Concrete measures are being implemented to reduce energy consumption, emissions and optimize water use, and an eco-validation platform has been introduced to monitor the supply chain, which will be expanded over the next three years to 100% of its suppliers.

Bormioli Pharma 15 July 2021